- Home
- CARG vs ZLAB Comparison
CARG vs ZLAB Comparison
Compare CARG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARG
- ZLAB
- Stock Information
- Founded
- CARG 2005
- ZLAB 2013
- Country
- CARG United States
- ZLAB China
- Employees
- CARG N/A
- ZLAB N/A
- Industry
- CARG EDP Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- CARG Technology
- ZLAB Health Care
- Exchange
- CARG Nasdaq
- ZLAB Nasdaq
- Market Cap
- CARG 3.2B
- ZLAB 3.6B
- IPO Year
- CARG 2017
- ZLAB 2017
- Fundamental
- Price
- CARG $33.70
- ZLAB $36.40
- Analyst Decision
- CARG Buy
- ZLAB Buy
- Analyst Count
- CARG 12
- ZLAB 5
- Target Price
- CARG $37.88
- ZLAB $54.28
- AVG Volume (30 Days)
- CARG 837.0K
- ZLAB 886.5K
- Earning Date
- CARG 08-07-2025
- ZLAB 08-05-2025
- Dividend Yield
- CARG N/A
- ZLAB N/A
- EPS Growth
- CARG 27.38
- ZLAB N/A
- EPS
- CARG 0.36
- ZLAB N/A
- Revenue
- CARG $903,746,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- CARG $7.60
- ZLAB $44.07
- Revenue Next Year
- CARG $8.07
- ZLAB $49.13
- P/E Ratio
- CARG $93.15
- ZLAB N/A
- Revenue Growth
- CARG 0.63
- ZLAB 43.72
- 52 Week Low
- CARG $21.65
- ZLAB $16.01
- 52 Week High
- CARG $41.33
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- CARG 62.35
- ZLAB 52.67
- Support Level
- CARG $33.00
- ZLAB $34.79
- Resistance Level
- CARG $34.35
- ZLAB $36.73
- Average True Range (ATR)
- CARG 0.80
- ZLAB 1.23
- MACD
- CARG 0.10
- ZLAB -0.46
- Stochastic Oscillator
- CARG 81.99
- ZLAB 25.91
About CARG CarGurus Inc.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.